Arteriosclerosis in rat aortic allografts: Early changes in endothelial integrity and smooth muscle phenotype

Transplantation

Volumn 70, Issue 1, 2000, Pages 65-72

  Bojakowski, Krzysztof ^a   Religa, Piotr ^a,b   Bojakowska, Maria ^a   Hedin, Ulf ^b   Gaciong, Zbigniew ^a   Thyberg, Johan ^c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA GRAFT; ARTERIOSCLEROSIS; ARTICLE; ENDOTHELIUM LESION; GRAFT SURVIVAL; HISTOPATHOLOGY; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE; SURVIVAL TIME;

ANIMALS; AORTA, ABDOMINAL; APOPTOSIS; ARTERIOSCLEROSIS; CALCINOSIS; CELL DIVISION; ENDOTHELIUM, VASCULAR; MALE; MICROSCOPY, ELECTRON; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE; RATS; RATS, INBRED F344; RATS, INBRED LEW; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034662148     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Akyürek ML. Cellular and molecular mechanisms in transplant arteriosclerosis. Int J Mol Med 1998; 1: 279.
2. Anderson HØ. Heart allograft vascular disease. An obliterative vascular disease in transplanted hearts. Atherosclerosis 1999; 142: 243.
3. McDonald PC, Kenyon JA, McManus BM. The role of lipids in transplant vascular disease. Lab Invest 1998; 78: 1187.
4. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115.
5. Mennander A, Tiisala S, Halttunen J, Yilmaz S, Paavonen T, Häyry P. Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis. Arterioscler Thromb 1991; 11: 671.
6. Plissonnier D, Levy BI, Salzmann J-L, Nochy D, Watelet J, Michel J-B. Allograft-induced arterial wall injury and response in normotensive and spontaneously hypertensive rats. Arterioscler Thromb 1991; 11: 1690.
7. Isik FF, McDonald TO, Ferguson M, Yamanaka E, Gordon D. Transplant arteriosclerosis in a rat aortic model. Am J Pathol 1992; 141: 1139.
8. Rhodin JAG. Architecture of the vessel wall. In: Bohr DF, Somlyo AP, Sparks HV Jr, eds. Handbook of physiology, cardiovascular system, vascular smooth muscle, vol II. Washington DC: Am Physiol Soc, 1980; 1.
9. Ross R, Fuster V. The pathogenesis of atherosclerosis. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven Publishers, 1996; 441.
10. Räisänen-Sokolowski A, Tilly-Kiesi M, Ustinov J, et al. Hyperlipidemia accelerates allograft arteriosclerosis (chronic rejection) in the rat. Arterioscler Thromb 1994; 14: 2032.
11. Schwartz SM, Reidy MA. Restenosis. An assessment of factors important in arterial occlusion. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven Publishers, 1996; 701.
12. Bauters C, Isner JM. The biology of restenosis. Progr Cardiovasc Dis 1997; 40: 107.
13. Thyberg J. Phenotypic modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury. Histol Histopathol 1998; 13: 871.
14. van Hinsbergh VWM. Endothelial permeability for macromolecules. Mechanistic aspects of pathophysiological modulation. Arterioscler Thromb Vasc Biol 1997; 17: 1018.
15. Penn MS, Rangaswamy S, Saidel GM, Chisolm GM. Macromolecular transport in the arterial intima: comparison of chronic and acute injuries. Am J Physiol 1997; 272: H1560.
16. DiCorleto PE, Gimbrone MA Jr. Vascular endothelium. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven Publishers, 1996; 387.
17. Amrani M, Yacoub MH. Endothelial function in myocardial protection. Curr Opin Cardiol 1996; 11: 559.
18. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 1996; 32: 743.
19. Wanders A, Akyürek ML, Waltenberger J, et al. Ischemia-induced transplant arteriosclerosis in the rat. Arterioscler Thromb Vasc Biol 1995; 15: 145.
20. Plissonier D, Nochy D, Poncet P, et al. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation 1995; 60: 414.
21. Gohra H, McDonald TO, Verrier ED, Aziz S. Endothelial loss and regeneration in a model of transplant arteriosclerosis. Transplantation 1995; 60: 96.
22. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71.
23. Grünwald J, Fingerle J, Hämmerle H, Betz E, Haudenschild CC. Cytocontractile structures and proteins of smooth muscle cells during the formation of experimental lesions. Exp Mol Pathol 1987; 46: 78.
24. Thyberg J, Blomgren K, Hedin U, Dryjski M. Phenotype modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: an electron-microscopic and stereological study. Cell Tissue Res 1995; 281: 421.
25. Campbell GR, Campbell JH, Manderson JA, Horrigan S, Rennick RE. Arterial smooth muscle: a multifunctional mesenchymal cell. Arch Pathol Lab Med 1988; 112: 977.
26. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995; 75: 487.
27. Thyberg J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol 1996; 169: 183.
28. Bobik A, Campbell JH. Vascular derived growth factors: cell biology, pathophysiology, and pharmacology. Pharmacol Rev 1993; 45: 1.
29. Zhao XM, Yeoh TK, Frist WH, Porterfield DL, Miller GG. Induction of acidic fibroblast growth factor and full-length platelet-derived growth factor expression in human cardiac allografts. Analysis by PCR, in situ hybridization, and immunohistochemistry. Circulation 1994; 90: 677.
30. Waltenberger J, Akyürek ML, Aurivillius M, et al. Ischemia-induced transplant arteriosclerosis in the rat. Induction of peptide growth factor expression. Arterioscler Thromb Vasc Biol 1996; 16: 1516.
31. Lemström KB, Koskinen PK. Expression and localization of platelet-derived growth factor ligand and receptor protein during acute and chronic rejection of rat cardiac allografts. Circulation 1997; 96: 1240.
32. Sihvola R, Koskinen P, Myllärniemi M, et al. Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor. Circulation 1999; 99: 2295.
33. Greaves DR, Gough PJ, Gordon S. Recent progress in defining the role of scavenger receptors in lipid transport, atherosclerosis and host defence. Curr Opin Lipidol 1998; 9: 425.
34. Stein O, Stein Y. Smooth muscle cells and atherosclerosis. Curr Opin Lipidol 1995; 6: 269.
35. Kerr JFR, Gobé GC, Winterford CM, Harmon BV. Anatomical methods in cell death. Methods Cell Biol 1995; 46: 1.
36. Granville DJ, Carthy CM, Hunt DWC, McManus BM. Apoptosis: molecular aspects of cell death and disease. Lab Invest 1998; 78: 893.
37. Haunstetter A, Izumo S. Apoptosis. Basic mechanisms and implications for cardiovascular disease. Circ Res 1998; 82: 1111.
38. Allaire E, Hasenstab D, Kenagy RD, Starcher B, Clowes MM, Clowes AW. Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1. Circulation 1998; 98: 249.
39. Nakamura H, Ohtsubo K. Ultrastructure appearance of atherosclerosis in human and experimentally-induced animal models. Electron Microsc Rev 1992; 5: 129.
40. Kim KM. Apoptosis and calcification. Scanning Microsc 1995; 9: 1137.
41. Kockx MM, Herman AG. Apoptosis in atherosclerosis: implications for plaque destabilization. Eur Heart J 1998; 19 (suppl): G23.